New study checks if obese patients get right acyclovir dose
NCT ID NCT02879630
First seen Apr 29, 2026 · Last updated Jun 21, 2026 · Updated 6 times
Summary
This study looked at whether a special weight-based dose of acyclovir works well in obese patients. Researchers enrolled 13 people already receiving acyclovir in the hospital and took blood samples over 12 hours to measure drug levels. The goal was to see if the adjusted dose provides similar drug exposure as in non-obese patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
West Virginia University Hospitals
Morgantown, West Virginia, 26506, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
acyclovir
What this could lead to
If successful, this could lead to better dosing guidelines for acyclovir in obese patients, ensuring they get the right amount of medicine.
What could go wrong
This is a very small study with only 13 participants, so results may not apply to everyone. It only measures drug levels, not actual health outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.